1 |
In vitro anti-cancer effects of gefitinib via EGF receptor-targeted delivery on triple-negative breast cancer cells Jae Won Ahn, Yeong Jun Song, Kyeongsoon Park Macromolecular Research, 31(9), 837, 2023 |
2 |
Cetuximab-anchored gold nanorod mediated photothermal ablation of breast cancer cell in spheroid model embedded with tumor associated macrophage Emami F, Banstola A, Jeong JH, Yook SM Journal of Industrial and Engineering Chemistry, 106, 177, 2022 |
3 |
Identification of FOXE3 transcription factor as a potent oncogenic factor in triple-negative breast cancer Wang H, Yang T, Yuan YY, Sun XM Biochemical and Biophysical Research Communications, 523(1), 78, 2020 |
4 |
Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines Muguruma M, Teraoka S, Miyahara K, Ueda A, Asaoka M, Okazaki M, Kawate T, Kuroda M, Miyagi Y, Ishikawa T Biochemical and Biophysical Research Communications, 533(3), 268, 2020 |
5 |
Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization Chen W, Bai YX, Patel C, Geng F Biochemical and Biophysical Research Communications, 520(2), 263, 2019 |
6 |
Expression of miRNAs Targeting mTOR and S6K1 Genes of mTOR Signaling Pathway Including miR-96, miR-557, and miR-3182 in Triple-Negative Breast Cancer Razaviyan J, Hadavi R, Tavakoli R, Kamani F, Paknejad M, Mohammadi-Yeganeh S Applied Biochemistry and Biotechnology, 186(4), 1074, 2018 |
7 |
Emergence of a Promising Lead Compound in the Treatment of Triple Negative Breast Cancer: An Insight into Conformational Features and Ligand Binding Landscape of c-Src Protein with UM-164 Ndagi U, Mhlongo NN, Soliman ME Applied Biochemistry and Biotechnology, 185(3), 655, 2018 |
8 |
RIP2 enhances cell survival by activation of NF-kappa B in triple negative breast cancer cells Jaafar R, Mnich K, Dolan S, Hillis J, Almanza A, Logue SE, Samali A, Gorman AM Biochemical and Biophysical Research Communications, 497(1), 115, 2018 |
9 |
Upregulation of circ-UBAP2 predicts poor prognosis and promotes triple-negative breast cancer progression through the miR-661/MTA1 pathway Wang ST, Li Q, Wang YF, Li XM, Wang R, Kang YH, Xue XK, Meng R, Wei Q, Feng XH Biochemical and Biophysical Research Communications, 505(4), 996, 2018 |
10 |
Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways Wang SQ, Yao YN, Yao MY, Fu PF, Wang WL Biochemical and Biophysical Research Communications, 503(3), 1605, 2018 |